Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV

Yulia Grishchuk, Katherine G. Stember, Aya Matsunaga, Ana M. Olivares, Nelly M. Cruz, Victoria E. King, Daniel M. Humphrey, Shirley L. Wang, Alona Muzikansky, Rebecca A. Betensky, Wallace B Thoreson, Neena Haider, Susan A. Slaugenhaupt

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Mucolipidosis IV is a debilitating developmental lysosomal storage disorder characterized by severe neuromotor retardation and progressive loss of vision, leading to blindness by the second decade of life. Mucolipidosis IV is caused by loss-of-function mutations in the MCOLN1 gene, which encodes the transient receptor potential channel protein mucolipin-1. Ophthalmic pathology in patients includes corneal haze and progressive retinal and optic nerve atrophy. Herein, we report ocular pathology in Mcoln1-/- mouse, a good phenotypic model of the disease. Early, but non-progressive, thinning of the photoreceptor layer, reduced levels of rhodopsin, disrupted rod outer segments, and widespread accumulation of the typical storage inclusion bodies were the major histological findings in the Mcoln1-/- retina. Electroretinograms showed significantly decreased functional response (scotopic a- and b-wave amplitudes) in the Mcoln1-/- mice. At the ultrastructural level, we observed formation of axonal spheroids and decreased density of axons in the optic nerve of the aged (6-month-old) Mcoln1-/- mice, which indicates progressive axonal degeneration. Our data suggest that mucolipin-1 plays a role in postnatal development of photoreceptors and provides a set of outcome measures that can be used for ocular therapy development for mucolipidosis IV.

Original languageEnglish (US)
Pages (from-to)199-209
Number of pages11
JournalAmerican Journal of Pathology
Volume186
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Mucolipidoses
Retinal Dystrophies
Optic Nerve
Pathology
Transient Receptor Potential Channels
Rod Cell Outer Segment
Optic Atrophy
Rhodopsin
Inclusion Bodies
Blindness
Axons
Retina
Outcome Assessment (Health Care)
Mutation
Genes
Proteins
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Grishchuk, Y., Stember, K. G., Matsunaga, A., Olivares, A. M., Cruz, N. M., King, V. E., ... Slaugenhaupt, S. A. (2016). Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV. American Journal of Pathology, 186(1), 199-209. https://doi.org/10.1016/j.ajpath.2015.09.017

Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV. / Grishchuk, Yulia; Stember, Katherine G.; Matsunaga, Aya; Olivares, Ana M.; Cruz, Nelly M.; King, Victoria E.; Humphrey, Daniel M.; Wang, Shirley L.; Muzikansky, Alona; Betensky, Rebecca A.; Thoreson, Wallace B; Haider, Neena; Slaugenhaupt, Susan A.

In: American Journal of Pathology, Vol. 186, No. 1, 01.01.2016, p. 199-209.

Research output: Contribution to journalArticle

Grishchuk, Y, Stember, KG, Matsunaga, A, Olivares, AM, Cruz, NM, King, VE, Humphrey, DM, Wang, SL, Muzikansky, A, Betensky, RA, Thoreson, WB, Haider, N & Slaugenhaupt, SA 2016, 'Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV', American Journal of Pathology, vol. 186, no. 1, pp. 199-209. https://doi.org/10.1016/j.ajpath.2015.09.017
Grishchuk Y, Stember KG, Matsunaga A, Olivares AM, Cruz NM, King VE et al. Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV. American Journal of Pathology. 2016 Jan 1;186(1):199-209. https://doi.org/10.1016/j.ajpath.2015.09.017
Grishchuk, Yulia ; Stember, Katherine G. ; Matsunaga, Aya ; Olivares, Ana M. ; Cruz, Nelly M. ; King, Victoria E. ; Humphrey, Daniel M. ; Wang, Shirley L. ; Muzikansky, Alona ; Betensky, Rebecca A. ; Thoreson, Wallace B ; Haider, Neena ; Slaugenhaupt, Susan A. / Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV. In: American Journal of Pathology. 2016 ; Vol. 186, No. 1. pp. 199-209.
@article{be7113df7d6b4d79a75b8c9a5245de1a,
title = "Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV",
abstract = "Mucolipidosis IV is a debilitating developmental lysosomal storage disorder characterized by severe neuromotor retardation and progressive loss of vision, leading to blindness by the second decade of life. Mucolipidosis IV is caused by loss-of-function mutations in the MCOLN1 gene, which encodes the transient receptor potential channel protein mucolipin-1. Ophthalmic pathology in patients includes corneal haze and progressive retinal and optic nerve atrophy. Herein, we report ocular pathology in Mcoln1-/- mouse, a good phenotypic model of the disease. Early, but non-progressive, thinning of the photoreceptor layer, reduced levels of rhodopsin, disrupted rod outer segments, and widespread accumulation of the typical storage inclusion bodies were the major histological findings in the Mcoln1-/- retina. Electroretinograms showed significantly decreased functional response (scotopic a- and b-wave amplitudes) in the Mcoln1-/- mice. At the ultrastructural level, we observed formation of axonal spheroids and decreased density of axons in the optic nerve of the aged (6-month-old) Mcoln1-/- mice, which indicates progressive axonal degeneration. Our data suggest that mucolipin-1 plays a role in postnatal development of photoreceptors and provides a set of outcome measures that can be used for ocular therapy development for mucolipidosis IV.",
author = "Yulia Grishchuk and Stember, {Katherine G.} and Aya Matsunaga and Olivares, {Ana M.} and Cruz, {Nelly M.} and King, {Victoria E.} and Humphrey, {Daniel M.} and Wang, {Shirley L.} and Alona Muzikansky and Betensky, {Rebecca A.} and Thoreson, {Wallace B} and Neena Haider and Slaugenhaupt, {Susan A.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.ajpath.2015.09.017",
language = "English (US)",
volume = "186",
pages = "199--209",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV

AU - Grishchuk, Yulia

AU - Stember, Katherine G.

AU - Matsunaga, Aya

AU - Olivares, Ana M.

AU - Cruz, Nelly M.

AU - King, Victoria E.

AU - Humphrey, Daniel M.

AU - Wang, Shirley L.

AU - Muzikansky, Alona

AU - Betensky, Rebecca A.

AU - Thoreson, Wallace B

AU - Haider, Neena

AU - Slaugenhaupt, Susan A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Mucolipidosis IV is a debilitating developmental lysosomal storage disorder characterized by severe neuromotor retardation and progressive loss of vision, leading to blindness by the second decade of life. Mucolipidosis IV is caused by loss-of-function mutations in the MCOLN1 gene, which encodes the transient receptor potential channel protein mucolipin-1. Ophthalmic pathology in patients includes corneal haze and progressive retinal and optic nerve atrophy. Herein, we report ocular pathology in Mcoln1-/- mouse, a good phenotypic model of the disease. Early, but non-progressive, thinning of the photoreceptor layer, reduced levels of rhodopsin, disrupted rod outer segments, and widespread accumulation of the typical storage inclusion bodies were the major histological findings in the Mcoln1-/- retina. Electroretinograms showed significantly decreased functional response (scotopic a- and b-wave amplitudes) in the Mcoln1-/- mice. At the ultrastructural level, we observed formation of axonal spheroids and decreased density of axons in the optic nerve of the aged (6-month-old) Mcoln1-/- mice, which indicates progressive axonal degeneration. Our data suggest that mucolipin-1 plays a role in postnatal development of photoreceptors and provides a set of outcome measures that can be used for ocular therapy development for mucolipidosis IV.

AB - Mucolipidosis IV is a debilitating developmental lysosomal storage disorder characterized by severe neuromotor retardation and progressive loss of vision, leading to blindness by the second decade of life. Mucolipidosis IV is caused by loss-of-function mutations in the MCOLN1 gene, which encodes the transient receptor potential channel protein mucolipin-1. Ophthalmic pathology in patients includes corneal haze and progressive retinal and optic nerve atrophy. Herein, we report ocular pathology in Mcoln1-/- mouse, a good phenotypic model of the disease. Early, but non-progressive, thinning of the photoreceptor layer, reduced levels of rhodopsin, disrupted rod outer segments, and widespread accumulation of the typical storage inclusion bodies were the major histological findings in the Mcoln1-/- retina. Electroretinograms showed significantly decreased functional response (scotopic a- and b-wave amplitudes) in the Mcoln1-/- mice. At the ultrastructural level, we observed formation of axonal spheroids and decreased density of axons in the optic nerve of the aged (6-month-old) Mcoln1-/- mice, which indicates progressive axonal degeneration. Our data suggest that mucolipin-1 plays a role in postnatal development of photoreceptors and provides a set of outcome measures that can be used for ocular therapy development for mucolipidosis IV.

UR - http://www.scopus.com/inward/record.url?scp=84955512389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955512389&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2015.09.017

DO - 10.1016/j.ajpath.2015.09.017

M3 - Article

VL - 186

SP - 199

EP - 209

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 1

ER -